Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2023/06/054027
CTRI/2023/06/054027Not yet recruitingNot Applicable

Musculoskeletal Disorders in Postmenopausal Women

Priyal Shah1 site in 1 country95 target enrollmentStarted: June 30, 2023Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
95
Locations
1
Primary Endpoint
cornell musculoskeletal discomfort questtionaire
Study OverviewEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

This is a observational study. In my study the postmenopausal women including in my inclusion criteria will be asseed and screened for the different musculoskeletal disorder. All the womens will be explained about the study in their own languge. They will be administered using cornell musculoskeletal discomfort questionnaire. Depending on the joint involvement they will be assesed in detail.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
40.00 Year(s) to 60.00 Year(s) (—)
Sex
Female

Inclusion Criteria

  • •All postmenopausal women (menopause for > 1 year).

Exclusion Criteria

  • •1.women with unnatural menopause 2.women on medication such as anxiolytic and antidepresaant 3.women having mental retardation 4.women diagnosed with neurological disorders, metabolic disorders.
  • •5.women diagnosed with malignancy 6.women hving musculoskeletal pain prior to menopause.

Outcomes

Primary Outcomes

cornell musculoskeletal discomfort questtionaire

Time Frame: Baseline

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Priyal Shah
Sponsor Class
Other [self]

Study Sites (1)

Loading locations...

Similar Trials

Not yet recruiting
Unknown
Problems in Musculoskeletal system in Women After Menopause
CTRI/2023/06/054027Priyal Shah
Terminated
Phase 3
Study of the Molecular Features of Postmenopausal Women With HR+ HER2-negative aBC on First-line Treatment With Ribociclib and Letrozole and, in Patients With a PIK3CA Mutation, on Second-line Treatment With Alpelisib Plus FulvestrantBreast Cancer
NCT03439046Novartis Pharmaceuticals287
Completed
Not Applicable
Characteristics and Management of Postmenopausal Women With Osteoporosis Treated With Prolia® in FrancePost Menopausal Osteoporosis
NCT02347865Amgen777
Completed
Not Applicable
Balance and Muscle Strength as Indicators of Fracture Risk in Postmenopausal WomenOsteoporosis
NCT06645600Beylikduzu State Hospital156
Completed
Not Applicable
The Effect of Progressive Relaxation Exercises on Sleep Quality and Fatigue in Postmenopausal PeriodPostmenopausal PeriodFatigueSleep Quality
NCT05483413Kutahya Health Sciences University63